-
-
Drug Metabolism and Bioanalysis
More LessDrug Metabolism and Bioanalysis is an interdisciplinary, peer-reviewed journal that publishes letters, original research papers, mini-reviews, and guest-edited issues in all important aspects of drug metabolism, pharmacokinetics, and bioanalysis.
The scope includes in vitro systems, including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate, and glutathione conjugates.
Additionally, LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, and method development and validation, are included, with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays. Topics covered in this interdisciplinary journal include:- Analytical Method and Drug Metabolism
- Bioavailability and Biopharmacy
- Cytochrome 450 Drug Metabolism
- Cytotoxicity
- Drug Absorption and Disposition
- Drug Biotransformation
- Drug Delivery System
- Drug-Drug Interaction
- Drug Food Interaction
- Drug Metabolizing Enzymes
- Drug Toxicology
- Drug Transporters
- Drugs and CYP2D6
- Factors Affecting Drug Metabolism
- Hepatic Metabolism of Drugs
- P-Glycoprotein and Transport Carriers
- Pharmacokinetics and Pharmacodynamics
- Phase I and II Drug Metabolism
- Reactive Metabolites
- Therapeutic Drug Monitoring
- Xenobiotics
-
-
-
Drug Metabolism and Bioanalysis Letters
More LessDrug Metabolism and Bioanalysis Letters publishes letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes and drug clinical trial studies on major advances in all areas of drug metabolism and bioanalysis.
In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates. LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, method development and validation with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays.
-
-
-
Drug Metabolism Letters
More LessDrug Metabolism Letters publishes short papers on major advances in all areas of drug metabolism and disposition. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of the Internet technology for both the submission and review of manuscripts. The journal covers the following areas:
In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.
-